Agios Pharmaceuticals Inc Hits New 52-Week High at $35.91 (AGIO)
Shares of Agios Pharmaceuticals (NASDAQ:AGIO) hit a new 52-week high during mid-day trading on Tuesday, American Banking News reports. The stock traded as high as $35.91 and last traded at $35.50, with a volume of 356,103 shares trading hands. The stock had previously closed at $30.36.
Agios Pharmaceuticals has a one year low of $15.77 and a one year high of $33.59. The stock’s 50-day moving average is $21.56 and its 200-day moving average is $24.8. The company’s market cap is $1.109 billion.
Agios Pharmaceuticals (NASDAQ:AGIO) last released its earnings data on Thursday, November 7th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.19. On average, analysts predict that Agios Pharmaceuticals will post $-1.62 earnings per share for the current fiscal year.
Agios Pharmaceuticals, Inc is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company’s ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (NASDAQ:AGIO) are treated.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.